πŸ‡ΊπŸ‡Έ FDA
Patent

US 11286264

Macrocyclic compounds and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 11286264 (Macrocyclic compounds and uses thereof) held by TURNING POINT THERAPEUTICS, INC. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K45/06, A61P, A61P35/00